Eisai Company, Limited

Mitsubishi Jidosha Kogyo Kabushiki Kaisha

Hitoshi Takeuchi

Hiroshi Shionoya

Nozomu Koyanagi

Haruyoshi Arai

Hironori Abe

Kazunori Handa

Daizo Ogino

Gunki Funatsu

A vehicle () has mounted therein an engine (), a first rotating electric machine (), and a second rotating electric machine (). The power of the engine () and the power of the first rotating electric machine () are separately transmitted from different power transmission paths () to drive wheels (). The power of the engine () is also transmitted to the second rotating electric machine () and utilized to generate electrical power. The vehicle () is provided with a connecting/disconnecting mechanism () on the power transmission path () that transmits the power of the first rotating electric machine () to the drive wheels (). A controller () of the vehicle () calculates a requested driving power of the vehicle (), and when the connecting/disconnecting mechanism () is shifted from a disengaged state to an engaged state to deal with an increase in the requested driving power while the engine () is running, makes the second rotating electric machine () power run and transmits power of the second rotating electric machine () to the drive wheels ().

Controller for vehicle

An immunopotentiator comprising the B chain of ricin as an active ingredient. The immunopotentiator serves to increase immune response to fungi, viruses and other microorganisms and is therefore effective for prevention or treatment of infectious diseases by such microorganisms.

Immunopotentiator comprising the B chain of ricin as an active ingredient

An immunopotentiator comprising ricin as an active ingredient. Ricin is a glucoprotein having a molecular weight of about 65,000 and can be used in the form of an aqueous solution. It is useful for prevention and treatment of bacterial and viral infections and cancer.

Immunopotentiator containing recin

An immunopotentiator comprising abrin as an active ingredient. Abrin is a glucoprotein having a molecular weight of about 65,000 and can be used in the form of an aqueous solution. It is useful for prevention and treatment of bacterial and viral infections.

Growing community of inventors

Tokyo, Japan

Hitoshi Takeuchi